Answers are grounded in this paper and cite their sources.
Background: Rapid antigen diagnostic tests provided a timely complement to molecular testing during the COVID-19 pandemic. This study assessed the diagnostic accuracy of the NasoCheck Comfort nasal antigen test against RT-PCR in Guédiawaye, Senegal. Methods: A prospective cross-sectional study was conducted at Dalal Jamm National Hospital Centre between 1 July and 31 August 2021. Two respiratory specimens were obtained during the same visit from each of 200 consenting adults: a nasal swab for NasoCheck Comfort and a naso-oropharyngeal swab for Sansure RT-PCR. Diagnostic accuracy, Wilson 95% confidence intervals (CIs) and Cohen’s kappa were calculated. Results: Two antigen tests were invalid (1.0%), leaving 198 analysable pairs; 78 (39.4%) were RT-PCR positive. There were 73 true-positive, 5 false-negative, 120 true-negative and no false-positive antigen results. Sensitivity was 93.6% (95% CI 85.9–97.2%), specificity 100.0% (96.9–100.0%), positive predictive value 100.0% (95.0–100.0%), negative predictive value 96.0% (91.0–98.3%) and overall accuracy 97.5% (94.2–98.9%). Cohen’s κ was 0.95. False-negative RT-PCR Ct values ranged from 24 to 28. Conclusion: In this 2021 laboratory cohort, NasoCheck Comfort showed high agreement with RT-PCR, with sensitivity and specificity point estimates above the WHO minimum performance benchmarks for antigen tests. Negative antigen results warrant clinical assessment and molecular confirmation when infection is still suspected.
No takes yet. Share an insight, caveat, or question.
Diakhaby et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: